Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise

AIMS: Canagliflozin is a sodium glucose co-transporter 2 inhibitor in development for type 2 diabetes mellitus (T2DM). The efficacy and safety of canagliflozin were evaluated in subjects with T2DM inadequately controlled with diet and exercise. METHODS: In this 26-week, randomized, double-blind, pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Stenlöf, K, Cefalu, W T, Kim, K-A, Alba, M, Usiskin, K, Tong, C, Canovatchel, W, Meininger, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593184/
https://www.ncbi.nlm.nih.gov/pubmed/23279307
http://dx.doi.org/10.1111/dom.12054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593184/
https://www.ncbi.nlm.nih.gov/pubmed/23279307
http://dx.doi.org/10.1111/dom.12054

Ejemplares similares